Novel Therapeutic Approaches in Inflammatory Bowel Diseases—the Fourth Edition

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".

Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 102

Special Issue Editor

Special Issue Information

Dear Colleagues,

Inflammatory bowel diseases (IBDs) such as Crohn’s disease and ulcerative colitis are chronic diseases of the gastrointestinal tract characterized by inflammation of the enteric wall, abdominal pain, diarrhea, bleeding and malabsorption.

Conventional therapies for IBD include anti-inflammatory drugs, corticosteroids, thiopurines, methotrexate and anti-tumor necrosis factor agents. The long-term use of these drugs can induce severe side effects, reducing patients’ quality of life. For this reason, there is great interest in finding new therapeutic strategies with fewer side effects for the treatment of IBDs.

The purpose of this Special Issue is to publish original research papers and/or relevant updates of the literature data on the beneficial effects of novel and safe treatments in gastrointestinal disorders.

Dr. Giovanni Pallio
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • IBD
  • colitis
  • Crohn’s disease
  • inflammation
  • cytokines
  • ROS
  • oxidative stress

Related Special Issue

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop